Unibest
← Back to patent-cliff list

CAS 1421372-94-2

N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine

Codes: OSIM-006, BPI-7711-001

Application context (from source-drug indications)

Non-small cell lung cancerOsimertinib MesylateNon-small cell lung cancerRezivertinib Mesylate

Source drugs (routes using this intermediate)

DrugTierExpiry
Osimertinib MesylateTier A — Act now2031
Rezivertinib MesylateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Rezivertinib MesylateOriginator routesteps: 3total yield: 0.583 g (BPI-7711)
BPI-7711→N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine→2-(dimethylamino)ethanol→N-(4-(2-(dimethylamino)ethoxy)-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine→4-(2-(dimethylamino)ethoxy)-6-methoxy-N1-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,3-diamine→3-chloropropanoyl chloride

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API WorksN-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.